Skip to main content
SpringerLink
Log in

Variability in the benefit of the novel oral anticoagulant agents in patients with non-valvular atrial fibrillation

  • CE - LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151

    Article  CAS  PubMed  Google Scholar 

  2. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891

    Article  CAS  PubMed  Google Scholar 

  3. Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992

    Article  CAS  PubMed  Google Scholar 

  4. Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093–2104

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Alvaro del Portillo, 200, 00128, Rome, Italy

    Giuseppe Patti & Ilaria Cavallari

Authors
  1. Giuseppe Patti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilaria Cavallari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Patti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patti, G., Cavallari, I. Variability in the benefit of the novel oral anticoagulant agents in patients with non-valvular atrial fibrillation. Intern Emerg Med 10, 395–396 (2015). https://doi.org/10.1007/s11739-014-1169-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-014-1169-1

Keywords

Search

Navigation